 |
Articles: General Pharma |
Prior Articles
Abbott Completes Acquisition of Evalve, Inc.
Abbott, 11/03/09
Advisory Panel OKs Privacy Standards
HealthDataManagement, 11/03/09 Xerox to Acquire ACS
HealthDataManagement, 11/03/09 User Groups Prove Helpful
HealthDataManagement, 11/03/09 AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call
AVI BioPharma, 11/03/09
Free full text
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
Array BioPharma, 11/03/09
Free full text
Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5
Cell Therapeutics, 11/03/09
Free full text
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Free full text
RHIO Gives Docs Access to Reports, Images
HealthDataManagement, 11/03/09 Health IT Stimulus Summit Offers Multiple Lessons
HealthDataManagement, 11/03/09 Online Resources Available
HealthDataManagement, 11/03/09 Nursing I.T. Award Nominations Sought
HealthDataManagement, 11/03/09 BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Amylin Pharmaceuticals, 11/02/09
Free full text
Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand
Watson Pharmaceuticals, 11/02/09
Free full text
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Free full text
More Tools Launched to Handle H1N1
HealthDataManagement, 11/02/09 ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone
Chugai Pharmaceutical Co., 11/02/09
Free full text
Morphine/naltrexone extended-release capsules (Embeda): Combination of mu-opioid agonist and mu-opioid antagonist approved for the management of moderate-to-severe pain when continuous analgesia is needed for an extended time period
Formulary, 11/02/09
Free full text
BARACLUDE Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Bristol Myers-Squibb Company, 11/02/09
Free full text
Telavancin for injection (Vibativ): Lipoglycopeptide antibiotic approved for the treatment of complicated skin and skin-structure infections
Formulary, 11/02/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
